Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 8 studies | 25% ± 9% | |
| basal cell | 8 studies | 23% ± 6% | |
| endothelial cell of vascular tree | 6 studies | 21% ± 3% | |
| endothelial cell | 4 studies | 21% ± 5% | |
| fibroblast | 4 studies | 21% ± 4% | |
| pericyte | 4 studies | 18% ± 3% | |
| erythroblast | 3 studies | 32% ± 6% | |
| abnormal cell | 3 studies | 20% ± 4% | |
| dendritic cell | 3 studies | 25% ± 6% | |
| intestinal crypt stem cell | 3 studies | 19% ± 3% | |
| smooth muscle cell | 3 studies | 20% ± 3% |
Insufficient scRNA-seq data for expression of NOP16 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 588.53 | 180 / 180 | 100% | 22.31 | 430 / 430 |
| uterus | 100% | 514.68 | 170 / 170 | 100% | 25.85 | 459 / 459 |
| esophagus | 100% | 945.11 | 1444 / 1445 | 100% | 20.80 | 183 / 183 |
| intestine | 100% | 694.37 | 966 / 966 | 100% | 31.09 | 526 / 527 |
| bladder | 100% | 802.57 | 21 / 21 | 100% | 26.50 | 503 / 504 |
| skin | 100% | 1148.23 | 1809 / 1809 | 100% | 24.28 | 471 / 472 |
| liver | 100% | 656.04 | 226 / 226 | 100% | 15.71 | 405 / 406 |
| prostate | 100% | 582.95 | 245 / 245 | 100% | 16.42 | 500 / 502 |
| stomach | 99% | 609.60 | 357 / 359 | 100% | 25.45 | 286 / 286 |
| breast | 100% | 752.05 | 459 / 459 | 99% | 18.20 | 1108 / 1118 |
| adrenal gland | 100% | 824.02 | 258 / 258 | 99% | 14.04 | 227 / 230 |
| kidney | 100% | 615.28 | 89 / 89 | 99% | 13.04 | 889 / 901 |
| lung | 98% | 563.40 | 569 / 578 | 100% | 17.66 | 1155 / 1155 |
| thymus | 99% | 490.02 | 648 / 653 | 99% | 10.24 | 599 / 605 |
| pancreas | 97% | 340.05 | 317 / 328 | 99% | 16.62 | 177 / 178 |
| brain | 93% | 347.70 | 2468 / 2642 | 100% | 14.26 | 705 / 705 |
| eye | 0% | 0 | 0 / 0 | 100% | 15.25 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 37.85 | 29 / 29 |
| muscle | 100% | 1516.02 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 694.21 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 23.05 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 16.79 | 1 / 1 |
| adipose | 100% | 920.97 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 517.05 | 1329 / 1335 | 0% | 0 | 0 / 0 |
| heart | 96% | 644.40 | 828 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 49% | 517.27 | 459 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0042273 | Biological process | ribosomal large subunit biogenesis |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | NOP16 |
| Protein name | Nucleolar protein 16 Nucleolar protein 16 (HBV pre-S2 trans-regulated protein 3) NOP16 nucleolar protein |
| Synonyms | HSPC111 CGI-117 |
| Description | |
| Accessions | D6RIC3 ENST00000509257.1 Q9Y3C1 ENST00000618911.4 [Q9Y3C1-3] A0A087WU10 D6RC60 ENST00000621444.4 A0A0C4DGU5 ENST00000616685.1 ENST00000502663.5 ENST00000614830.5 [Q9Y3C1-1] |
